Analyze Diet
Journal of veterinary internal medicine2025; 39(2); e70047; doi: 10.1111/jvim.70047

The Effect of Season and Breed on Hypothalamic-Pituitary-Adrenal Axis Hormones, Metabolic Hormones, and Oxidative Markers in Ponies and Horses.

Abstract: Endocrine function in ponies differs from horses, with seasonally increased concentrations of plasma adrenocorticotropic hormone (ACTH) and an increased risk of insulin dysregulation. Objective: (1) Season and breed differences exist in concentrations of hypothalamic-pituitary-adrenal axis and metabolic hormones; and (2) systemic oxidative status is significantly different between ponies and horses and correlates with endocrine hormones. Methods: Thirty-four healthy Welsh ponies and 14 healthy Quarter horses. Methods: Blood was collected from Welsh ponies and Quarter horses in the same region during the same weeks in May and October. Concentrations of plasma ACTH, insulin, leptin, derivatives of reactive oxygen metabolites (dROMs), plasma antioxidant capacity (PAC), and serum total cortisol, percent-free cortisol, and estimated free cortisol concentrations were measured. Linear mixed effects modeling with a random effect for animal was used to determine the effects of season and breed. Correlation coefficients were calculated for relevant variables. Statistical significance was set at p < 0.05. Results: Fall plasma ACTH concentration was significantly higher in ponies compared with horses (p < 0.001). Total cortisol concentration was significantly lower in ponies in fall compared with spring (p = 0.05; 95% confidence interval [CI] = 0.005-0.934). Insulin concentrations in ponies were significantly higher in fall compared with spring (p < 0.001) and compared with horses in fall (p < 0.001). In horses, PAC was higher in fall than in spring (p = 0.01; 95% CI = -730.2T to -99.26). Correlations varied with season and breed. Conclusions: Season and breed significantly affect the HPA axis, metabolic hormones, and oxidative status. Our results support breed consideration when interpreting endocrine testing results in horses.
Publication Date: 2025-03-06 PubMed ID: 40048369PubMed Central: PMC11884412DOI: 10.1111/jvim.70047Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research examines the effects of season and breed on various hormones and oxidative markers in ponies and horses. The study found significant differences in hormone concentrations and oxidative status between Welsh ponies and Quarter horses, with these differences varying across different seasons.

Research Objectives

  • The research aimed to determine whether there are differences in the concentrations of hypothalamic-pituitary-adrenal (HPA) axis and metabolic hormones between different seasons and breeds.
  • The study also aimed to understand whether the systemic oxidative status differs between ponies and horses and if this correlates with endocrine hormones.

Methodology

  • The researchers selected 34 healthy Welsh ponies and 14 healthy Quarter horses for the study.
  • Blood samples were taken from these animals during the same weeks in May and October in the same region.
  • The concentrations of various hormones and derivatives, such as plasma adrenocorticotropic hormone (ACTH), insulin, leptin, derivatives of reactive oxygen metabolites (dROMs), plasma antioxidant capacity (PAC), and serum total cortisol, were measured.
  • Statistical methods like linear mixed effects modeling were applied, with a random effect for the animal to find the impacts of the season and breed. Correlation coefficients for relevant variables were calculated with statistical significance set at p < 0.05.

Results

  • The study found that in fall, the concentration of plasma ACTH was significantly higher in ponies compared to horses. Moreover, in ponies, the total cortisol concentration was significantly lower in fall compared to spring.
  • Insulin concentrations in ponies were significantly higher in fall compared with spring, and also higher than those in horses during fall.
  • In horses, the plasma antioxidant capacity (PAC) was higher in fall than in spring.
  • The correlations varied with season and breed, highlighting the affect they can have on hormone concentrations and oxidative status.

Conclusions

  • The research concluded that both season and breed have significant effects on the HPA axis, metabolic hormones, and oxidative status in horses and ponies.
  • The results suggest that breed should be taken into consideration when interpreting endocrine testing results in horses.

Cite This Article

APA
Vaughn SA, Lemons MB, Hart KA. (2025). The Effect of Season and Breed on Hypothalamic-Pituitary-Adrenal Axis Hormones, Metabolic Hormones, and Oxidative Markers in Ponies and Horses. J Vet Intern Med, 39(2), e70047. https://doi.org/10.1111/jvim.70047

Publication

ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 39
Issue: 2
Pages: e70047
PII: e70047

Researcher Affiliations

Vaughn, Sarah Alison
  • University of Georgia, Department of Large Animal Medicine, Athens, USA.
Lemons, Margaret B
  • University of Georgia, Department of Large Animal Medicine, Athens, USA.
Hart, Kelsey A
  • University of Georgia, Department of Large Animal Medicine, Athens, USA.

MeSH Terms

  • Horses / physiology
  • Horses / blood
  • Animals
  • Adrenocorticotropic Hormone / blood
  • Hypothalamo-Hypophyseal System / metabolism
  • Pituitary-Adrenal System / physiology
  • Seasons
  • Hydrocortisone / blood
  • Male
  • Insulin / blood
  • Female
  • Leptin / blood
  • Oxidative Stress
  • Biomarkers / blood
  • Reactive Oxygen Species / blood

Grant Funding

  • D20EQ-035 / Morris Animal Foundation

Conflict of Interest Statement

Dr. Kelsey Hart has served as an unpaid consultant for and had travel expenses covered by Boehringer Ingelheim, producer of a Food and Drug Administration (FDA) labeled treatment for pituitary pars intermedia dysfunction in horses. She was not involved in the selection of animals for sampling. Classification of animals was decided using the published consensus statement's recommended cut‐off values. The other authors declare no conflicts of interest.

References

This article includes 59 references
  1. Ireland JL, McGowan CM. Epidemiology of Pituitary Pars Intermedia Dysfunction: A Systematic Literature Review of Clinical Presentation, Disease Prevalence and Risk Factors. Veterinary Journal 235 (2018): 22–33.
    doi: 10.1016/J.TVJL.2018.03.002pubmed: 29704935google scholar: lookup
  2. McFarlane D. Equine Pituitary Pars Intermedia Dysfunction. Veterinary Clinics of North America. Equine Practice 27, no. 1 (2011): 93–113.
    doi: 10.1016/J.CVEQ.2010.12.007pubmed: 21392656google scholar: lookup
  3. Hillyer MH, Taylor FGR, Mair TS, Murphy D, Watson TDG, Love S. Diagnosis of Hyperadrenocorticism in the Horse. Equine Veterinary Education 4, no. 3 (1992): 131–134.
  4. van der Kolk JH, Kalsbeek HC, van Garderen E, Wensing T, Breukink HJ. Equine Pituitary Neoplasia: A Clinical Report of 21 Cases (1990‐1992). Veterinary Record 133, no. 24 (1993): 594–597.
    pubmed: 8116170
  5. Couëtil L, Paradis MR, Knoll J. Plasma Adrenocorticotropin Concentration in Healthy Horses and in Horses With Clinical Signs of Hyperadrenocorticism. Journal of Veterinary Internal Medicine 10, no. 1 (1996): 1–6.
  6. Donaldson MT, LaMonte BH, Morresey P, Smith G, Beech J. Treatment With Pergolide or Cyproheptadine of Pituitary Pars Intermedia Dysfunction (Equine Cushing's Disease). Journal of Veterinary Internal Medicine 16, no. 6 (2002): 742–746.
  7. McGowan CM, Neiger R. Efficacy of Trilostane for the Treatment of Equine Cushing's Syndrome. Equine Veterinary Journal 35, no. 4 (2003): 414–418.
    pubmed: 12880011
  8. Chandler KJ, Dixon RM. Urinary Cortisol:Creatinine Ratios in Healthy Horses and Horses With Hyperadrenocorticism and Non‐Adrenal Disease. Veterinary Record 150, no. 25 (2002): 773–776.
    doi: 10.1136/vr.150.25.773pubmed: 12135071google scholar: lookup
  9. McFarlane D, Holbrook TC. Cytokine Dysregulation in Aged Horses and Horses With Pituitary Pars Intermedia Dysfunction. Journal of Veterinary Internal Medicine 22, no. 2 (2008): 436–442.
  10. McGowan TW, Pinchbeck GP, McGowan CM. Prevalence, Risk Factors and Clinical Signs Predictive for Equine Pituitary Pars Intermedia Dysfunction in Aged Horses. Equine Veterinary Journal 45, no. 1 (2013): 74–79.
  11. McGowan T. W., Aged Horse Health, Management and Welfare (School of Animal Studies, The University of Queensland, 2008).
  12. Tatum RC, Mcgowan CM, Ireland JL. Evaluation of the Sensitivity and Specificity of Basal Plasma Adrenocorticotrophic Hormone Concentration for Diagnosing Pituitary Pars Intermedia Dysfunction in Horses: A Systematic Review. Veterinary Journal 275 (2021): 1090–1233.
    doi: 10.1016/j.tvjl.2021.105695pubmed: 34099343google scholar: lookup
  13. Bamford N, Harris P, Bailey S. Circannual Variation in Plasma Adrenocorticotropic Hormone Concentrations and Dexamethasone Suppression Test Results in Standardbred Horses, Andalusian Horses and Mixed‐Breed Ponies. Australian Veterinary Journal 98, no. 12 (2020): 616–621.
    doi: 10.1111/AVJ.13022pubmed: 33001453google scholar: lookup
  14. Vaughn SA, Norton NA, Hart KA. Circulating Hypothalamic‐Pituitary‐Adrenal Axis Hormones and Insulin Concentrations in Horses and Ponies. Journal of Equine Veterinary Science 111 (2022): 103810.
    doi: 10.1016/J.JEVS.2021.103810pubmed: 35219029google scholar: lookup
  15. Durham AE, Potier JF, Huber L. The Effect of Month and Breed on Plasma Adrenocorticotropic Hormone Concentrations in Equids. Veterinary Journal 286 (2022): 1090–1233.
    doi: 10.1016/j.tvjl.2022.105857pubmed: 35798232google scholar: lookup
  16. Bamford NJ, Stewart AJ, El‐Hage CM, Bertin FR, Bailey SR. Investigation of Breed Differences in Plasma Adrenocorticotropic Hormone Concentrations Among Healthy Horses and Ponies. Veterinary Journal 296 (2023): 105995.
    doi: 10.1016/J.TVJL.2023.105995pubmed: 37207985google scholar: lookup
  17. Bailey SR, Habershon‐Butcher JL, Ransom KJ, Elliott J, Menzies‐Gow NJ. Hypertension and Insulin Resistance in a Mixed‐Breed Population of Ponies Predisposed to Laminitis. American Journal of Veterinary Research 69, no. 1 (2008): 122–129.
    doi: 10.2460/ajvr.69.1.122pubmed: 18167097google scholar: lookup
  18. Horn R, Stewart AJ, Jackson KV, Dryburgh EL, Medina‐Torres CE, Bertin FR. Clinical Implications of Using Adrenocorticotropic Hormone Diagnostic Cutoffs or Reference Intervals to Diagnose Pituitary Pars Intermedia Dysfunction in Mature Horses. Journal of Veterinary Internal Medicine 35, no. 1 (2021): 560–570.
    doi: 10.1111/JVIM.16017pmc: PMC7848300pubmed: 33368633google scholar: lookup
  19. Secombe CJ, Tan RHH, Devindri Perara I, Byrne DP, Watts SP, Wearn JG. The Effect of Geographic Location on Circannual Adrenocorticotropic Hormone Plasma Concentrations in Horses in Australia. Journal of Veterinary Internal Medicine 31, no. 5 (2017): 1533–1540.
    doi: 10.1111/JVIM.14782pmc: PMC5598888pubmed: 28661009google scholar: lookup
  20. Copas V, Durham A. Circannual Variation in Plasma Adrenocorticotropic Hormone Concentrations in the UK in Normal Horses and Ponies, and Those With Pituitary Pars Intermedia Dysfunction. Equine Veterinary Journal 44, no. 4 (2012): 440–443.
  21. Durham AE, Clarke BR, Potier JFNN, Hammarstrand R, Malone GL. Clinically and Temporally Specific Diagnostic Thresholds for Plasma ACTH in the Horse. Equine Veterinary Journal 53, no. 2 (2021): 250–260.
    doi: 10.1111/evj.13292pubmed: 32470177google scholar: lookup
  22. Bamford NJ, Potter SJ, Harris PA, Bailey SR. Breed Differences in Insulin Sensitivity and Insulinemic Responses to Oral Glucose in Horses and Ponies of Moderate Body Condition Score. Domestic Animal Endocrinology 47, no. 1 (2014): 101–107.
  23. Treiber KH, Kronfeld DS, Hess TM, Byrd BM, Splan RK, Staniar WB. Evaluation of Genetic and Metabolic Predispositions and Nutritional Risk Factors for Pasture‐Associated Laminitis in Ponies. Journal of the American Veterinary Medical Association 228, no. 10 (2006): 1538–1545.
    doi: 10.2460/javma.228.10.1538pubmed: 16677122google scholar: lookup
  24. Wilmink JM, Veenman JN, van den Boom R. Differences in Polymorphonucleocyte Function and Local Inflammatory Response Between Horses and Ponies. Equine Veterinary Journal 35, no. 6 (2003): 561–569.
    pubmed: 14515955
  25. Norton EM, Schultz NE, Rendahl AK. Heritability of Metabolic Traits Associated With Equine Metabolic Syndrome in Welsh Ponies and Morgan Horses. Equine Veterinary Journal 51, no. 4 (2019): 475–480.
    doi: 10.1111/evj.13053pubmed: 30472742google scholar: lookup
  26. McFarlane D, Dybdal N, Donaldson MT, Miller L, Cribb AE. Nitration and Increased Alpha‐Synuclein Expression Associated With Dopaminergic Neurodegeneration in Equine Pituitary Pars Intermedia Dysfunction. Journal of Neuroendocrinology 17, no. 2 (2005): 73–80.
  27. McFarlane D, Cribb AE. Systemic and Pituitary Pars Intermedia Antioxidant Capacity Associated With Pars Intermedia Oxidative Stress and Dysfunction in Horses. American Journal of Veterinary Research 66, no. 12 (2005): 2065–2072.
    doi: 10.2460/ajvr.2005.66.2065pubmed: 16379648google scholar: lookup
  28. Żak A, Siwińska N, Chełmecka E. Effects of Advanced Age, Pituitary Pars Intermedia Dysfunction and Insulin Dysregulation on Serum Antioxidant Markers in Horses. Antioxidants 9, no. 5 (2020): 1–13.
    doi: 10.3390/antiox9050444pmc: PMC7278619pubmed: 32455574google scholar: lookup
  29. . Consensus Statement: Recommendations for the Diagnosis and Treatment of Pituitary Pars Intermedia Dysfunction (PPID). Equine Endocrinology Group 2019.
  30. Henneke DR, Potter GD, Kreider JL, Yeates BF. Relationship Between Condition Score, Physical Measurements and Body Fat Percentage in Mares. Equine Veterinary Journal 15, no. 4 (1983): 371–372.
  31. Singh AK, Jiang Y, White T, Spassova D. Validation of Nonradioactive Chemiluminescent Immunoassay Methods for the Analysis of Thyroxine and Cortisol in Blood Samples Obtained From Dogs, Cats, and Horses. Journal of Veterinary Diagnostic Investigation 9, no. 3 (1997): 261–268.
    doi: 10.1177/104063879700900307pubmed: 9249165google scholar: lookup
  32. McFarlane D, Donaldson MT, McDonnell SM, Cribb AE. Effects of Season and Sample Handling on Measurement of Plasma Alpha‐Melanocyte‐Stimulating Hormone Concentrations in Horses and Ponies. American Journal of Veterinary Research 65, no. 11 (2004): 1463–1468.
    pubmed: 15566081
  33. Hart KA, Wochele DM, Norton NA, McFarlane D, Wooldridge AA, Frank N. Effect of Age, Season, Body Condition, and Endocrine Status on Serum Free Cortisol Fraction and Insulin Concentration in Horses. Journal of Veterinary Internal Medicine 30, no. 2 (2016): 653–663.
    doi: 10.1111/jvim.13839pmc: PMC4913614pubmed: 26860336google scholar: lookup
  34. Barsnick RJIM, Hurcombe SDA, Smith PA. Insulin, Glucagon, and Leptin in Critically Ill Foals. Journal of Veterinary Internal Medicine 25, no. 1 (2011): 123–131.
  35. Hart KA, Barton MH, Ferguson DC. Serum Free Cortisol Fraction in Healthy and Septic Neonatal Foals. Journal of Veterinary Internal Medicine 25, no. 2 (2011): 345–355.
  36. Vaughn SA, Norton NA, Hurley DJ, Hart KA. Validation of a Commercially Available Photometric Analytical System for Assessment of Plasma Oxidative Status in Healthy Horses. Veterinary Immunology and Immunopathology 265 (2023): 110665.
    doi: 10.1016/J.VETIMM.2023.110665pubmed: 37952346google scholar: lookup
  37. Donaldson MT, Mcdonnell SM, Schanbacher BJ, Lamb SV, Mcfarlane D, Beech J. Variation in Plasma Adrenocorticotropic Hormone Concentration and Dexamethasone Suppression Test Results With Season, Age, and Sex in Healthy Ponies and Horses. Journal of Veterinary Internal Medicine 19 (2005): 217–222.
    pubmed: 15822567
  38. McGowan TW, Pinchbeck GP, McGowan CM. Evaluation of Basal Plasma α‐Melanocyte‐Stimulating Hormone and Adrenocorticotrophic Hormone Concentrations for the Diagnosis of Pituitary Pars Intermedia Dysfunction From a Population of Aged Horses. Equine Veterinary Journal 45, no. 1 (2013): 66–73.
  39. McFarlane D, Paradis MR, Zimmel D. The Effect of Geographic Location, Breed, and Pituitary Dysfunction on Seasonal Adrenocorticotropin and α‐Melanocyte‐Stimulating Hormone Plasma Concentrations in Horses. Journal of Veterinary Internal Medicine 25, no. 4 (2011): 872–881.
  40. Ayala I, Martos NF, Silvan G, Gutierrez‐Panizo C, Clavel JG, Carlos Illera J. Cortisol, Adrenocorticotropic Hormone, Serotonin, Adrenaline and Noradrenaline Serum Concentrations in Relation to Disease and Stress in the Horse. Research in Veterinary Science 93 (2012): 103–107.
    doi: 10.1016/j.rvsc.2011.05.013pubmed: 21641009google scholar: lookup
  41. Jacob SI, Geor RJ, Weber PSD, Harris PA, McCue ME. Effect of Dietary Carbohydrates and Time of Year on ACTH and Cortisol Concentrations in Adult and Aged Horses. Domestic Animal Endocrinology 63 (2018): 15–22.
  42. Cordero M, Brorsen BW, McFarlane D. Circadian and Circannual Rhythms of Cortisol, ACTH, and α‐Melanocyte‐Stimulating Hormone in Healthy Horses. Domestic Animal Endocrinology 43, no. 4 (2012): 317–324.
  43. Knowles EJ, Moreton‐Clack MC, Shaw S, Harris PA, Elliott J, Menzies‐Gow NJ. Plasma Adrenocorticotropic Hormone (ACTH) Concentrations in Ponies Measured by Two Different Assays Suggests Seasonal Cross‐Reactivity or Interference. Equine Veterinary Journal 50, no. 5 (2018): 672–677.
    doi: 10.1111/EVJ.12797pubmed: 29247453google scholar: lookup
  44. McGilvray TA, Knowles EJ, Harris PA, Menzies‐Gow NJ. Comparison of Immunofluorescence and Chemiluminescence Assays for Measuring ACTH in Equine Plasma. Equine Veterinary Journal 52, no. 5 (2020): 709–714.
    doi: 10.1111/EVJ.13227pubmed: 31955443google scholar: lookup
  45. Chergui N, Mormede P, Foury A, Khammar F, Amirat Z. Seasonal Effects on Plasma Cortisol Concentrations in the Bedouin Buck: Circadian Studies and Response to ACTH. Animal 11, no. 3 (2017): 445–451.
    doi: 10.1017/S1751731116001671pubmed: 27510620google scholar: lookup
  46. Li R, Jia Z, Trush MA. Defining ROS in Biology and Medicine. React Oxyg Species 1, no. 1 (2016): 9.
    doi: 10.20455/ROS.2016.803pmc: PMC5921829pubmed: 29707643google scholar: lookup
  47. Stolarczyk E. Adipose Tissue Inflammation in Obesity: A Metabolic or Immune Response?. Current Opinion in Pharmacology 37 (2017): 35–40.
    doi: 10.1016/j.coph.2017.08.006pubmed: 28843953google scholar: lookup
  48. Basinska K, Marycz K, Śmieszek A, Nicpoń J. The Production and Distribution of IL‐6 and TNF‐α in Subcutaneous Adipose Tissue and Their Correlation With Serum Concentrations in Welsh Ponies With Equine Metabolic Syndrome. Journal of Veterinary Science 16, no. 1 (2015): 113–120.
    doi: 10.4142/jvs.2015.16.1.113pmc: PMC4367141pubmed: 25269712google scholar: lookup
  49. Suagee JK, Corl BA, Crisman MV, Pleasant RS, Thatcher CD, Geor RJ. Relationships Between Body Condition Score and Plasma Inflammatory Cytokines, Insulin, and Lipids in a Mixed Population of Light‐Breed Horses. Journal of Veterinary Internal Medicine 27, no. 1 (2013): 157–163.
    doi: 10.1111/JVIM.12021pubmed: 23216530google scholar: lookup
  50. Vick MM, Adams AA, Murphy BA. Relationships Among Inflammatory Cytokines, Obesity, and Insulin Sensitivity in the Horse. Journal of Animal Science 85, no. 5 (2007): 1144–1155.
    doi: 10.2527/jas.2006-673pubmed: 17264235google scholar: lookup
  51. Salak JL, McGlone JJ, Lyte M. Effects of In Vitro Adrenocorticotrophic Hormone, Cortisol and Human Recombinant Interleukin‐2 on Porcine Neutrophil Migration and Luminol‐Dependent Chemiluminescence. Veterinary Immunology and Immunopathology 39, no. 4 (1993): 327–337.
    doi: 10.1016/0165-2427(93)90065-Cpubmed: 8116214google scholar: lookup
  52. Ichiyama T, Sato S, Okada K, Catania A, Lipton JM. The Neuroimmunomodulatory Peptide Alpha‐MSH. Annals of the New York Academy of Sciences 917 (2000): 221–226.
  53. Holbrook TC, Tipton T, McFarlane D. Neutrophil and Cytokine Dysregulation in Hyperinsulinemic Obese Horses. Veterinary Immunology and Immunopathology 145, no. 1–2 (2012): 283–289.
    doi: 10.1016/j.vetimm.2011.11.013pubmed: 22169327google scholar: lookup
  54. Irvine CHG, Alexander SL. Factors Affecting the Circadian Rhythm in Plasma Cortisol Concentrations in the Horse. Domestic Animal Endocrinology 11, no. 2 (1994): 227–238.
    doi: 10.1016/0739-7240(94)90030-2pubmed: 8045104google scholar: lookup
  55. Evans JW, Winget CM, Pollak EJ. Rhythmic Cortisol Secretion in the Equine: Analysis and Physiological Mechanisms. J Interdiscipl Cycle Res 8, no. 2 (2008): 111–121.
    doi: 10.1080/09291017709359550google scholar: lookup
  56. Hoffsis G, Murdick P, Tharp V, Ault K. Plasma Concentrations of Cortisol and Corticosterone in the Normal Horse. American Journal of Veterinary Research 31, no. 8 (1970): 1379–1387.
    pubmed: 4317816
  57. Chewning S, Baker L, Pipkin J, Douglas R, Mitchell P. 1 Daily Secretion Patterns of Thyroxine, Insulin, and Cortisol in Non‐Working Horses on Pasture When Receiving One Concentrate Meal per Day vs. no Daily Concentrate. Journal of Equine Veterinary Science 100 (2021): 103464.
  58. . Consensus Statement: Recommendations for the Diagnosis and Treatment of Equine Metabolic Syndrome (EMS). 2020.
  59. Fitzgerald DM, Anderson ST, Sillence MN, De Laat MA. The Cresty Neck Score Is an Independent Predictor of Insulin Dysregulation in Ponies. PLoS One 14, no. 7 (2019): e0220203.

Citations

This article has been cited 0 times.